Pre-Filled Syringe, Autoinjector And Pen Injector Solutions For GLP-1 Applications
Glucagon-like peptide-1 (GLP-1) treatments have demonstrated remarkable effectiveness in addressing major public health issues, including diabetes and obesity.
Accelerate and derisk your GLP-1 drug development programs with Aptar Pharma’s reliable packaging solutions, including rigid needle shields (RNS), pre-filled syringe (PFS) and cartridge plungers. Our advanced parenteral closure solutions help optimize and secure your fill-finish operations.
Injectables
Injectables
Delivery Routes
-
Delivery Routes
- Eye Care
- Dermal
- Other Routes
Nasal Drug Delivery
Nasal Drug Delivery
Inhalation Drug Delivery
Inhalation Drug Delivery
-
Inhalation Drug Delivery
- Inhalation Drug Delivery Overview
Injectables
Injectables
Oral Liquid Dispensing
Oral Liquid Dispensing
-
Oral Liquid Dispensing
- Oral Liquid Dispensing
- Liquid Nutritional Supplements
- Oral Liquid Delivery Frequently Asked Questions
Accelerate And Derisk The Development Of Your GLP-1 Drugs For Diabetes And Obesity Treatments
Platform of pre-filled system components
Glucagon-like peptide-1 (GLP-1) based self-injection drugs for type 2 diabetes and obesity often rely on autoinjectors or pen injector systems to ensure their safe and effective administration by patients.
Aptar Pharma offers a range of high-quality components to support your GLP-1 product development needs:
- Pre-filled syringe (PFS) plungers
- Rigid needle shields (RNS)
- Cartridge plungers for pen-injectors
Take your development from formulation to patient with Aptar Pharma’s drug development services, innovative solutions and patient services that support the success of your self-injected GLP-1 drug products for diabetes and obesity.
Ensure your long-term security of supply of GLP-1 injectable components
With a growing market for diabetes and obesity treatments, securing your long-term security of supply of GLP-1 self-injection components is essential. We continue to expand our injectable component manufacturing capabilities, leveraging robotization and clean room manufacturing capacity to ensure you receive ever-increasing quality worldwide.
With a new factory in Europe, new manufacturing lines in the US and worldwide upgrade plans, we are investing in capabilities to support your drug developments needs and transform your expectations of what an injectable partner should be.
Accelerate and derisk your GLP-1 drug and delivery device development
When developing glucagon-like peptide-1 (GLP-1) drugs, such as for diabetes or obesity, the compatibility of the formulation with the primary container is a major concern that could potentially delay regulatory approval.
Leverage Aptar Pharma’s pure rubber component formulation, market proven component designs and clean room manufacturing capabilities to promote drug to component compatibility. For your most sensitive drug development programs, choose PremiumCoat® ETFE film-coated plungers to further reduce the risks related to extractables, and leachables.
Facilitate your choice of primary packaging
Selecting the right primary packaging partner is essential to derisk your regulatory review and reduce time-to-market. World-leading glass-manufacturing and pharmaceutical companies have already validated our pre-filled syringe component solutions and are partnering with us to develop self-injection devices for glucagon-like peptide-1 (GLP-1) and a wide range of other applications.
Support your brand image and differentiate your GLP-1 drug
As GLP-1 drugs are getting more attention and global competition increases, differentiation will become essential for the success of your injectable drug. Customize your parenteral drug delivery solutions with us, meeting your specific requirements and supporting your brand image.
Product Details
Contact Aptar Pharma’s Parenteral Expert Team Today
Learn more about how we can support your compliance with EMA GMP Annex 1 revisions and optimize your operations with our advanced injectable packaging solutions.
Recently Published Resources
Optimizing Autoinjector Performance for Drug Development
Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions
Enhanced Injection Experience with Pre-Filled Syringe Solutions
Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions
Advancing GLP-1 Drug Developments with Integrated Solutions
Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions
Sustainability at the Heart of Aptar Pharma’s Expansion
Publications, Pharmaceutical, Sustainability
